Cathie Wood: portfolio of ARK Investment Management

Cathie Wood leads ARK Investment Management, which offers actively managed funds focused on technology and innovation.

Source: 13F filing with the US Securities and Exchange Commission dated Jul 30, 2019. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

You are looking at Q2 2019. Go to the latest filing (Q3 2026)

4.0B USDQ2 2019
Total value of stock positions
4.0B USD
Positions
229
Share of the ten largest
50.0%

The ten largest positions Q2 2019

  1. Lendingclub Corp 8.5%new
  2. Tesla, Inc. 6.5%▲ +54.3%
  3. Stratasys Ltd 5.7%▲ +6.2%
  4. Invitae Corp 5.6%▲ +7.9%
  5. Illumina, Inc. 5.0%▲ +15.1%
  6. Block, Inc. 4.6%▲ +17.5%
  7. Nvidia 4.4%▼ −16.9%
  8. Intellia Therapeutics Inc 3.4%▲ +3.3%
  9. Crispr Therapeutics AG 3.2%▲ +34.7%
  10. Editas Medicine Inc 3.0%▲ +6.3%
Total value of stock positions per quarter, Q4 2016 to Q3 2026 (peak 53.7B USD).
Choose a quarter (40 filings)

All positions Q2 2019

Positions Q2 2019 per 13F filing, 53 of 53
Symbol Weight Shares Reported value Change Held since
Lendingclub Corp 8.5% 20,659,636 338.8M USD new Q2 2019 1 quarter
Pluristem Therapeutics Inc 0.8% 5,156,645 32.0M USD new Q2 2019 1 quarter
META Meta Platforms 0.8% 162,707 31.4M USD new Q2 2019 1 quarter
Arcturus Therapeutics Ltd 0.2% 1,004,368 9.5M USD new Q2 2019 1 quarter
Jumia Technologies Ag-Adr 0.2% 272,881 7.2M USD new Q2 2019 1 quarter
Roku Inc 0.2% 77,425 7.0M USD new Q2 2019 1 quarter
Guardant Health Inc 0.2% 74,041 6.4M USD new Q2 2019 1 quarter
Twist Bioscience Corp 0.2% 213,793 6.2M USD new Q2 2019 1 quarter
Personalis Inc 0.1% 197,720 5.4M USD new Q2 2019 1 quarter
Caredx Inc 0.1% 127,608 4.6M USD new Q2 2019 1 quarter
Fate Therapeutics Inc 0.1% 222,064 4.5M USD new Q2 2019 1 quarter
Meituan Dianping-Class B < 0.1% 201,600 3.2M USD new Q2 2019 1 quarter
Straumann Holding Ag-Reg < 0.1% 3,109 2.7M USD new Q2 2019 1 quarter
Renishaw PLC < 0.1% 42,556 2.3M USD new Q2 2019 1 quarter
Conformis Inc < 0.1% 438,015 1.9M USD new Q2 2019 1 quarter
Hilan Ltd < 0.1% 17,566 1.4M USD new Q2 2019 1 quarter
Dassault Systemes SA < 0.1% 8,172 1.3M USD new Q2 2019 1 quarter
Altair Engineering Inc - A < 0.1% 30,327 1.2M USD new Q2 2019 1 quarter
Brainsway Ltd < 0.1% 82,313 863.0K USD new Q2 2019 1 quarter
Matrix It Ltd < 0.1% 35,995 729.0K USD new Q2 2019 1 quarter
Aerojet Rocketdyne Holdings < 0.1% 11,973 536.0K USD new Q2 2019 1 quarter
Bet Shemesh Engines Holdings < 0.1% 19,677 502.0K USD new Q2 2019 1 quarter
Partner Communications Co < 0.1% 112,426 472.0K USD new Q2 2019 1 quarter
Allot Ltd < 0.1% 61,698 445.0K USD new Q2 2019 1 quarter
Aeronautics Ltd < 0.1% 116,127 409.0K USD new Q2 2019 1 quarter
Siemens Ag-Reg < 0.1% 3,208 384.0K USD new Q2 2019 1 quarter
Oc Oerlikon Corp Ag-Reg < 0.1% 29,151 356.0K USD new Q2 2019 1 quarter
Kaiser Aluminum Corp < 0.1% 3,609 352.0K USD new Q2 2019 1 quarter
Bertrandt AG < 0.1% 4,666 331.0K USD new Q2 2019 1 quarter
Mediwound Ltd < 0.1% 96,097 325.0K USD new Q2 2019 1 quarter
TMO Thermo Fisher Scientific < 0.1% 897 263.0K USD new Q2 2019 1 quarter
Henkel AG & Co Kgaa < 0.1% 996 98.0K USD new Q2 2019 1 quarter
Arkema SA < 0.1% 960 90.0K USD new Q2 2019 1 quarter
Sgl Carbon SE < 0.1% 5,553 38.0K USD new Q2 2019 1 quarter
DD DuPont < 0.1% 421 32.0K USD new Q2 2019 1 quarter
Bayer AG Reg < 0.1% 390 27.0K USD new Q2 2019 1 quarter
Sandvik AB < 0.1% 2,813 16.0K USD new Q2 2019 1 quarter
Corteva Inc < 0.1% 421 12.0K USD new Q2 2019 1 quarter
Evonik Industries AG < 0.1% 1,621 5.0K USD new Q2 2019 1 quarter
Koninklijke Dsm NV < 0.1% 445 4.0K USD new Q2 2019 1 quarter
Daimler Ag-Unsponsored ADR 0.0% 0 0.0 USD new –
Hortonworks Inc 0.0% 0 0.0 USD new –
Loxo Oncology Inc 0.0% 0 0.0 USD new –
Pacific Biosciences Of Calif 0.0% 0 0.0 USD new –
Prodways Group SA 0.0% 0 0.0 USD new –
Red Hat Inc 0.0% 0 0.0 USD new –
Redfin Corp 0.0% 0 0.0 USD new –
Sarepta Therapeutics Inc 0.0% 0 0.0 USD new –
Spark Therapeutics Inc 0.0% 0 0.0 USD new –
LIN Linde plc 0.0% 0 0.0 USD new –
Orbotech Ltd 0.0% 0 0.0 USD new –
Pointer Telocation Ltd 0.0% 0 0.0 USD new –
Suny Cellular Communication 0.0% 0 0.0 USD new –

“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.

Breakdown by sector

  • Technology 9.2%
  • Consumer Discretionary 7.3%
  • Health Care 6.6%
  • Financials 5.1%
  • Communication Services 1.9%
  • Industrials 0.1%
  • Materials 0.0%
  • not in our coverage 69.7%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close